A Study to Observe the Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) as an Augmentation Therapy in Pharmaco-resistant OCD - NI

Dept of Psychiatry RNT Medical College and MB GOVERNMENT HOSPITA0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1. Response failure to previous or current use of medication or psychotherapy ( response failure was defined as scores more than 16 at Y BOCS despite atleast two SSRI trials of adequate dose and duration)
•2. Stable medication regimen 8- 10 weeks before the intervention and unchanged during the treatment (4-6weeks)

•1. Previous treatment with electroconvulsive therapy, and presence or history of psychosis, substance abuse, suicide attempt and or active suicide ideation, neurological disorder, epilepsy, seizures, and head injury or loss of consciousness
•2. According to the safety criteria for rTMS, patients with implanted devices, metal bodies, cardiac arrhythmia, unstable medical conditions, or pregnancy, were also excluded.
•3. Patients diagnosed with any other comorbid psychiatric illness except depression and anxiety
•4. Patients diagnosed with any other chronic physical illness

发起方

Dept of Psychiatry RNT Medical College and MB GOVERNMENT HOSPITA